期刊
THERAPEUTICS AND CLINICAL RISK MANAGEMENT
卷 14, 期 -, 页码 247-256出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/TCRM.S151424
关键词
black-grained wheat; glycated albumin; tumor necrosis factor-alpha; interleukin-6
资金
- Agricultural Science and Technology Innovation Program of Chinese Academy of Agricultural Sciences on Minor Grain Nutrition Function
Introduction: Although black-grained wheat (BGW) is recognized as a nutritional food for humans in China, it has yet to be utilized well for industrial applications, which can be attributed to the limited research data available on its health benefits. Thus, the hypothesis was tested that a daily substitution of BGW for a partial staple food would improve glycemia and inflammatory profile of type 2 diabetes mellitus (T2DM) patients by a randomized controlled trial. Materials and methods: A total of 120 patients were randomly divided between control group (diet control and nutritional education) and BGW group (daily substitution of BGW for a partial staple food). Results: Based on the significant difference between BGW and control groups (P < 0.05), the primary outcomes were that BGW treatment in diet resulted in a significant lowering of glycated albumin (GA, 18.05 to 16.06 mmol/L) level in T2DM patients after a 5-week intervention, and this treatment regimen was much more efficient than the strategy of diet control alone. In addition, BGW supplementation prevented the increase in tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 induced by T2DM. There were no significant differences in blood glucose, glycated hemoglobin or insulin levels between the 2 groups. The subgroup analyses of the BGW daily intake showed that, except the TNF-alpha, significant improvements in GA and IL-6 were observed when the BGW intake dose was >69 g/day. Conclusion: These findings support the hypothesis that BGW may improve glycemia and the inflammatory profile in T2DM patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据